Regulatory recommendations for HLA-B*15:02 genotyping combined with government subsidy for the test also contributed to a reduction in CBZ-related SJS/TEN in Singapore by >90%, with additional reductions in number of phenytoin-related SJS/TEN cases (Sung et al., 2020). The gene discussed is HLA-B; the disease is toxic epidermal necrolysis.